Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study
-
* Corresponding author: Andrea Morelli andrea.morelli@uniroma1.it
Critical Care 2009, 13:R130 doi:10.1186/cc7990
See related commentary by Leone, http://ccforum.com/content/13/5/192
Evaulated on
Faculty of 1000
Accesses
- Last 30 days: 132 accesses
- Last 365 days: 1414 accesses
- All time: 6025 accesses